Insmed Inc. buy UBS Group AG
Start price
06.01.26
/
50%
€149.00
Target price
06.01.27
-
Performance (%)
-17.62%
Price
17.04.26
€120.36
Summary
This prediction is currently active. The price of Insmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -17.62%. This prediction currently runs until 06.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -8.290% | -8.290% |
| iShares Core DAX® | 3,59 % | 3,93 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % |
| iShares S&P 500 | 4,14 % | 4,04 % |
Comments by UBS_Group_AG for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for INSM provided by MarketBeat